Rankings
▼
Calendar
OABI Q4 2021 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena
OABI
OmniAb, Inc.
$231M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15M
+14.6% YoY
Gross Profit
$12M
78.9% margin
Operating Income
-$3M
-21.7% margin
Net Income
-$3M
-20.1% margin
EPS (Diluted)
$-0.00
QoQ Revenue Growth
+143.4%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$304M
Total Liabilities
$70M
Stockholders' Equity
$234M
Cash & Equivalents
$0
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$13M
+14.6%
Gross Profit
$12M
$13M
-9.6%
Operating Income
-$3M
-$2M
-38.4%
Net Income
-$3M
-$159,000
-1832.1%
← FY 2021
All Quarters
Q1 2022 →